Erythromycin a oxime (CAS No: 13127-18-9) is a key pharmaceutical intermediate used in the synthesis of APIs Azithromycin. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Erythromycin-9-oxime, 9-Hydroxyiminoerythromycin
CAS No: 13127-18-9
PubChem CID: 57347513
Mol Formula: C37H68N2O13
Mol Weight: 748.9 g/mol
Used in API: Azithromycin
IUPAC Name: (3R,4S,5S,6R,7R,9R,11S,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-10-hydroxyimino-4 -Show More
API Intermediate Description: Erythromycin Oxime is a semi-synthetic derivative of erythromycin designed to improve acid stability and oral bioavailability. It exhibits antibacterial activity by inhibiting bacterial protein synthesis via binding to the 50S ribosomal subunit.
